Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page
- Check5 days agoChange DetectedA consolidated Locations section now lists California, Florida, Massachusetts, and Texas as study sites, replacing the separate location headers, and the page revision has been updated to v3.3.3.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedPublications section text updated to note PubMed auto-population of articles, and the page now displays Revision: v3.3.2. This replaces the earlier wording about PubMed publications and Revision: v3.2.0.SummaryDifference0.1%

- Check41 days agoChange DetectedA government funding status notice was removed from the page.SummaryDifference0.3%

- Check55 days agoChange DetectedNo additions or deletions detected on the Study Details page for NCT02926833; the content and structure appear the same across the screenshots.SummaryDifference0.4%

- Check84 days agoChange Detected- Page now includes a government operating status notice and directs to official sources for updates. - Version updated from v3.1.0 to v3.2.0. - Adds a new resource topic: Malignant lymphoma, large B-cell, diffuse.SummaryDifference3%

- Check91 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.